Claudio Ronco Italy

Claudio Ronco
Claudio Ronco Senior lecturer, DIMED, University of Padova, Italy Director International Renal Research Institute of Vicenza (IRRIV) C/O Department of Nephrology Dialysis and Transplantation San Bortolo Hospital, Vicenza, Italy Claudio Ronco is Emeritus Professor of Medicine and Senior Lecturer of Nephrology at the University of Padova, Italy. He is also director of the International Renal Research Institute (IRRIV) at the Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy. He graduated in 1976 and specialised in nephrology at the University of Padua in 1979 and subsequently in pediatric nephrology in 1986. He has been Director of the Laboratory of the RRI and Beth Israel MC in New York and professor of Medicine at the Albert Einstein College of Medicine in 1999 and 2000. He is external professor at the University of Virginia of Charlottesville and the University Fudan and Jao tong of Shanghai. He received the Honorary degree at the University of Patras. He authored 1824 papers, 95 books and 195 book chapters and delivered more than 1650 lectures at international meetings. His H-index is 152. He is Editor-in-Chief of Blood Purification, Contributions to Nephrology, Cardiorenal Medicine and Editor emeritus of the International Journal of Artificial Organs. He is the founder of ADQI (Acute Disease Quality Initiative). He is the organizer of the International Vicenza course on AKI, CRRT and ECOS. He has received several international awards including the Belding Scribner Lifetime achievement award by the American Society of Nephrology and the Bywaters Award for AKI from the International Society of Nephrology. He is considered the pioneer in many areas of nephrology including peritoneal dialysis, critical care nephrology, CRRT, Hemoperfusion, cardiorenal syndromes and wearable dialysis technology. He invented the first CRRT machine for neonates CARPEDIEM (Cardio Renal Pediatric Dialysis Emergency Machine). He has been appointed with the highest Honor of the Italian Republic

18th September 2026 Friday

Time Session
08:00
15:30
Physician Track (CRRT Principle / Advanced CRRT Management / CRRT Equipment Demonstration)
(Pre-Congress Workshop)
  • Opening Remark
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Yu-Wei Fang Moderator
    Yu-Juei Hsu Moderator
  • Patient Selection, Modality, Dose
    Manish Kaushik Speaker
    Yu-Juei Hsu Moderator
    Yu-Wei Fang Moderator
  • The ABC of the CRRT Prescription
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Yu-Juei Hsu Moderator
    Yu-Wei Fang Moderator
  • Access, Membrane, Circuit
    Manish Kaushik Speaker
    Yu-Juei Hsu Moderator
    Yu-Wei Fang Moderator
  • Anticoagulation
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Yu-Juei Hsu Moderator
    Yu-Wei Fang Moderator
  • Q & A
  • Coffee Break
  • Solution and Fluid Balance
    Nuttha Lumlertgul Speaker Solution and Fluid BalanceUtility of Lung Ultrasound, VEXUS and Bioimpedance Analysis in Volume Assessment During RRT Personalized Fluid Management with CRRT
    Szu-Chun Hung Moderator
    Wayne Wei-Cheng Chen Moderator
  • Dysnatremia and Acid-Base Disorders
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Szu-Chun Hung Moderator
    Wayne Wei-Cheng Chen Moderator
  • Connectology with Hybrid Systems: ECMO, Apheresis, ECCO2R
    Keith Wille Speaker Connectology with Hybrid Systems: ECMO, Apheresis, ECCO2RAKI in the Mechanical Circulatory SupportHow do I care for the Patient with ARDS and AKI
    Szu-Chun Hung Moderator
    Wayne Wei-Cheng Chen Moderator
  • Hemoadsorption in the ICU
    Claudio Ronco Speaker Hemoadsorption in the ICUSpecial lecture: 50 years of CRRT: a journey through innovationRole of Renal Functional Reserve on AKI risk and RecoveryHow do I use Hemadsorption in My PracticeManaging the Heart Failure Patient With Worsening Renal Function (WRF)
    Szu-Chun Hung Moderator
    Wayne Wei-Cheng Chen Moderator
  • System Based Approaches for CRRT Management
    Ravindra Mehta Speaker
    Szu-Chun Hung Moderator
    Wayne Wei-Cheng Chen Moderator
  • Lunch
  • 1. Prismax
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Manish Kaushik Speaker
  • 2. Multifiltrate Pro
    John Prowle Speaker Trajectories of Critical Illness – Defining Endotypes from Routine DataDynamic Prescription of CRRT Ready for Prime TimeAdapting CRRT for patients with Electrolyte and acid-base disordersExtracorporeal Therapies in Trauma, Burns and Cerebral Edema
    Lui Forni Speaker Sepsis Associated AKIBicarbonate therapy for AKI or Bicarbonate in AKI: Use and MisuseAdapting CRRT for Patients with Electrolyte and Acid-Base Disorders
  • 3. CytoSorb
    Vedran Premužic Speaker
    Zsolt Molnár Speaker
  • 4. ECMO with CRRT, plasmaphresis
    Keith Wille Speaker Connectology with Hybrid Systems: ECMO, Apheresis, ECCO2RAKI in the Mechanical Circulatory SupportHow do I care for the Patient with ARDS and AKI
    Nuttha Lumlertgul Speaker Solution and Fluid BalanceUtility of Lung Ultrasound, VEXUS and Bioimpedance Analysis in Volume Assessment During RRT Personalized Fluid Management with CRRT
Room 1

19th September 2026 Saturday

Time Session
08:30
10:15
Plenary 1: Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
Chih-Wei Yang Moderator
Room 1
10:45
12:30
Plenary 2: AKI Pathophysiology
Shih-Chi Ku Moderator
Room 1

20th September 2026 Sunday

Time Session
07:30
08:15
Meet the Expert 5
How Do I Use Hemadsorption in My Practice
Hou-Tai Chang Moderator
  • How Do I Use Hemadsorption in My Practice
    Claudio Ronco Speaker Hemoadsorption in the ICUSpecial lecture: 50 years of CRRT: a journey through innovationRole of Renal Functional Reserve on AKI risk and RecoveryHow do I use Hemadsorption in My PracticeManaging the Heart Failure Patient With Worsening Renal Function (WRF)
    Thomas Rimmele Speaker Managing Patients with Sepsis: modifying the course with ECOSImmune Disorders of AKI Patients Following Various Types of InjuriesHow do I use Hemadsorption in My Practice
Room 2
14:00
15:30
Workshop 2 - Session G
Managing the Heart Failure Patient With Worsening Renal Function (WRF)
Wen-Chin Lee Moderator
Yafei Yang Moderator
Room 3